Gruppo Italiano per lo Studio della Streptochinasi nell’Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet1986; 1: 397–402.
2.
TavazziLMaggioniAPTognoniG. Participation versus education: the GISSI story and beyond. Am Heart J2004; 148: 222–229.
3.
YusufS. Transforming the scientific, health care, and sociopolitical culture of an entire country through clinical research: the story of GISSI. Am Heart J2004; 148: 193–195.
4.
AntmanEMHarringtonRA. Transforming clinical trials in cardiovascular disease: mission critical for health and economic well-being. JAMA2012; 308: 1743–1744.
5.
VickersAJ. Clinical trials in crisis: four simple methodological fixes. Clin Trials2014; 11: 615–621.
6.
LauerMSD’AgostinoRBSr. The randomized registry trial—the next disruptive technology in clinical research?N Engl J Med2013; 369: 1579–1581.
7.
EapenZJLauerMSTempleRJ. The imperative of overcoming barriers to the conduct of large, simple trials. JAMA2014; 311: 1397–1398.
8.
GordonDTaddei-PetersWMascetteA. Publication of trials funded by the National Heart, Lung, and Blood Institute. N Engl J Med2013; 369: 1926–1934.
9.
TricociPAllenJMKramerJM. Scientific evidence underlying the ACC/AHA clinical practice guidelines. JAMA2009; 301: 831–841.
10.
FadenRRBeauchampTLKassNE. Informed consent, comparative effectiveness, and learning health care. N Engl J Med2014; 370: 766–768.
11.
WilfondBSMagnusDAntommariaAH. The OHRP and SUPPORT. N Engl J Med2013; 368: e36.
12.
IngelfingerJRDrazenJM. Patient organizations and research on rare diseases. N Engl J Med2011; 364: 1670–1671.
13.
CollinsFSHudsonKLBriggsJP. PCORnet: turning a dream into reality. J Am Med Inform Assoc2014; 21: 576–577.
